Jacobs Bette 4
4 · Shuttle Pharmaceuticals Holdings, Inc. · Filed Dec 20, 2023
Insider Transaction Report
Form 4
Jacobs Bette
Director
Transactions
- Sale
Common Stock
2023-12-13$0.46/sh−4,157$1,926→ 27,064 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.
- [F2]Consists of (i) 15,201 shares of common stock and (ii) 11,863 RSUs which remain subject to certain vesting conditions.